Discover how HOA-correcting scleral lenses are revolutionizing visual improvements for irregular cornea patients and reducing glare and halos in low light environments.
Presbyopia-correcting intraocular lenses deliver a substantial lifestyle improvement, so offering them is becoming the new standard of care among cataract surgeons.
While these spectacle lenses are not yet approved by the US Food and Drug Administration, it’s likely a nod from the organization is not too far off. As a result, discussing the factors that influence treatment success makes sense.
Several studies do establish diabetes as a risk factor for glaucoma, and that diabetes with coexisting glaucoma increases the risk of developing diabetic retinopathy.
Optometric Management
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
May 01, 2025
Explore the cutting-edge advancements and collaborative discussions in retinal care at the Retina World Congress.
Explore the case of a 17-year-old girl with a rare genetic mutation causing vision instability and the successful use of scleral lenses for improved visual stability.
By virtue of being the primary eye care provider, optometrists are often the first to diagnose diabetic retinopathy (DR). As a result, patients both rely on and expect us to provide education on DR and the treatments available to them.